MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Innamorati, G.
Right arrow Articles by Birnbaumer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Innamorati, G.
Right arrow Articles by Birnbaumer, M.

A fully active nonglycosylated V2 vasopressin receptor

G Innamorati, H Sadeghi and M Birnbaumer

Department of Anesthesiology and Molecular Biology Institute, UCLA School of Medicine 90095, USA.

The human V2 vasopressin receptor belongs to the superfamily of G protein-coupled receptors believed to be anchored to the plasma membrane by seven transmembrane regions. The extracellular portion of the human V2 vasopressin receptor contains one site susceptible to N- linked glycosylation. Metabolic labeling and immunoprecipitation of the receptor expressed in transfected cells were applied to examine whether the protein was indeed glycosylated. The V2 vasopressin receptor expressed transiently was glycosylated, but glycosidase treatment to test the complexity of the sugar moiety linked to asparagine revealed that the majority of the receptor protein lacked complex carbohydrates, an indication of an improperly processed protein. This immature protein displayed a tendency to form aggregates. In contrast with these data, testing of the sugar complexity of the receptor protein synthesized in stably transfected cells identified the predominant form as an appropriately processed receptor protein. Mutagenesis of asparagine 22 to glutamine produced on expression in transfected cells a nonglycosylated receptor with ligand binding affinity and coupling characteristics almost identical to those of the wild-type form. After exposure to elevated concentrations of AVP (100 nM), the nonglycosylated form desensitized to the same extent as the wild-type receptor.

Volume 50, Issue 3, pp. 467-473, 09/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B. Yangthara, A. Mills, V. Chatsudthipong, L. Tradtrantip, and A. S. Verkman
Small-Molecule Vasopressin-2 Receptor Antagonist Identified by a G-Protein Coupled Receptor "Pathway" Screen
Mol. Pharmacol., July 1, 2007; 72(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Madziva and M. Birnbaumer
A Role for ADP-ribosylation Factor 6 in the Processing of G-protein-coupled Receptors
J. Biol. Chem., April 28, 2006; 281(17): 12178 - 12186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Bouley, H. Y. Lin, M. K. Raychowdhury, V. Marshansky, D. Brown, and D. A. Ausiello
Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1390 - C1401.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J.H. Robben, N.V.A.M. Knoers, and P.M.T. Deen
Regulation of the Vasopressin V2 Receptor by Vasopressin in Polarized Renal Collecting Duct Cells
Mol. Biol. Cell, December 1, 2004; 15(12): 5693 - 5699.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Tan, H. H. Nickols, and L. E. Limbird
Appropriate Polarization following Pharmacological Rescue of V2 Vasopressin Receptors Encoded by X-linked Nephrogenic Diabetes Insipidus Alleles Involves a Conformation of the Receptor That Also Attains Mature Glycosylation
J. Biol. Chem., September 12, 2003; 278(37): 35678 - 35686.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Birnbaumer
The V2 vasopressin receptor mutations and fluid homeostasis
Cardiovasc Res, August 15, 2001; 51(3): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Nagayama, E. Nishihara, H. Namba, S. Yamashita, and M. Niwa
Identification of the Sites of Asparagine-Linked Glycosylation on the Human Thyrotropin Receptor and Studies on Their Role in Receptor Function and Expression
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 404 - 409.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Ludwig, J. E. Ehlert, H.-D. Flad, and E. Brandt
Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N-Glycosylation Is Essential for Maintenance of Receptor Surface Expression
J. Immunol., July 15, 2000; 165(2): 1044 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. ALBERTAZZI, D. ZANCHETTA, P. BARBIER, S. FARANDA, A. FRATTINI, P. VEZZONI, M. PROCACCIO, A. BETTINELLI, F. GUZZI, M. PARENTI, et al.
Nephrogenic Diabetes Insipidus: Functional Analysis of New AVPR2Mutations Identified in Italian Families
J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1033 - 1043.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Jayadev, R. D. Smith, G. Jagadeesh, A. J. Baukal, L. Hunyady, and K. J. Catt
N-Linked Glycosylation Is Required for Optimal AT1a Angiotensin Receptor Expression in COS-7 Cells
Endocrinology, May 1, 1999; 140(5): 2010 - 2017.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Ray, P. Clapp, P. K. Goldsmith, and A. M. Spiegel
Identification of the Sites of N-Linked Glycosylation on the Human Calcium Receptor and Assessment of Their Role in Cell Surface Expression and Signal Transduction
J. Biol. Chem., December 18, 1998; 273(51): 34558 - 34567.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Schülein, R. Hermosilla, A. Oksche, M. Dehe, B. Wiesner, G. Krause, and W. Rosenthal
A Dileucine Sequence and an Upstream Glutamate Residue in the Intracellular Carboxyl Terminus of the Vasopressin V2 Receptor Are Essential for Cell Surface Transport in COS.M6 Cells
Mol. Pharmacol., September 1, 1998; 54(3): 525 - 535.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
X. Zhu, M. Jiang, and L. Birnbaumer
Receptor-activated Ca2+ Influx via Human Trp3 Stably Expressed in Human Embryonic Kidney (HEK)293 Cells. EVIDENCE FOR A NON-CAPACITATIVE Ca2+ ENTRY
J. Biol. Chem., January 2, 1998; 273(1): 133 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Boulay, X. Zhu, M. Peyton, M. Jiang, R. Hurst, E. Stefani, and L. Birnbaumer
Cloning and Expression of a Novel Mammalian Homolog of Drosophila Transient Receptor Potential (Trp) Involved in Calcium Entry Secondary to Activation of Receptors Coupled by the Gq Class of G Protein
J. Biol. Chem., November 21, 1997; 272(47): 29672 - 29680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Sadeghi, G. L. Robertson, D. G. Bichet, G. Innamorati, and M. Birnbaumer
Biochemical Basis of Partial Nephrogenic Diabetes Insipidus Phenotypes
Mol. Endocrinol., November 1, 1997; 11(12): 1806 - 1813.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
H. M. Sadeghi, G. Innamorati, M. Dagarag, and M. Birnbaumer
Palmitoylation of the V2 Vasopressin Receptor
Mol. Pharmacol., July 1, 1997; 52(1): 21 - 29.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
H. M. Sadeghi, G. Innamorati, and M. Birnbaumer
An X-Linked NDI Mutation Reveals a Requirement for Cell Surface V2R Expression
Mol. Endocrinol., June 1, 1997; 11(6): 706 - 713.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Fan, P. K. Goldsmith, R. Collins, C. K. Dunn, K. J. Krapcho, K. V. Rogers, and A. M. Spiegel
N-Linked Glycosylation of the Human Ca2+ Receptor Is Essential for Its Expression at the Cell Surface
Endocrinology, May 1, 1997; 138(5): 1916 - 1922.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Innamorati, H. Sadeghi, A. N. Eberle, and M. Birnbaumer
Phosphorylation of the V2 Vasopressin Receptor
J. Biol. Chem., January 24, 1997; 272(4): 2486 - 2492.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Birnbaumer, X. Zhu, M. Jiang, G. Boulay, M. Peyton, B. Vannier, D. Brown, D. Platano, H. Sadeghi, E. Stefani, et al.
On the molecular basis and regulation of cellular capacitative calcium entry: Roles for Trp proteins
PNAS, December 24, 1996; 93(26): 15195 - 15202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Innamorati, C. Le Gouill, M. Balamotis, and M. Birnbaumer
The Long and the Short Cycle. ALTERNATIVE INTRACELLULAR ROUTES FOR TRAFFICKING OF G-PROTEIN-COUPLED RECEPTORS
J. Biol. Chem., April 13, 2001; 276(16): 13096 - 13103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Erlenbach, E. Kostenis, C. Schmidt, C. S.-L. Gal, D. Raufaste, M. E. Dumont, M. H. Pausch, and J. Wess
Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis
J. Biol. Chem., July 27, 2001; 276(31): 29382 - 29392.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics